Risk Factors and Utility of a Risk-Based Algorithm for Monitoring Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections in Pediatric Recipients after Allogeneic Hematopoietic Cell Transplantation-Reference-Cited by-同舟云学术

Risk Factors and Utility of a Risk-Based Algorithm for Monitoring Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections in Pediatric Recipients after Allogeneic Hematopoietic Cell Transplantation

Published:2016-09 Issue:9 Volume:22 Page:1646-1653
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Rustia Evelyn,Violago Leah,Jin Zhezhen,Foca Marc D.,Kahn Justine M.,Arnold Staci,Sosna Jean,Bhatia Monica,Kung Andrew L.,George Diane,Garvin James H.,Satwani Prakash^ORCID

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference35 articles.

1. Making strides and meeting challenges in pediatric allogeneic hematopoietic cell transplantation clinical trials in the United States: Past, present and future;Satwani;Contemp Clin Trials,2015

2. Haematopoietic stem cell transplantation trends in children over the last three decades: a survey by the paediatric diseases working party of the European Group for Blood and Marrow Transplantation;Miano;Bone Marrow Transplant,2007

3. Reduced-intensity conditioning allogeneic stem cell transplantation in pediatric patients and subsequent supportive care;Barrell;Oncol Nurs Forum,2012

4. Reduced mortality after allogeneic hematopoietic-cell transplantation;Gooley;N Engl J Med,2010

5. Reducing the risk for transplantation-related mortality after allogeneic hematopoietic cell transplantation: how much progress has been made?;Horan;J Clin Oncol,2011

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Approach for defining human adenovirus infection and disease for central review adjudication in clinical studies;Pediatric Transplantation;2024-04-16

2. Busulfan with 400 centigray of total body irradiation and higher dose fludarabine: An alternative regimen for hematopoietic stem cell transplantation in pediatric acute lymphoblastic leukemia;Pediatric Blood & Cancer;2024-01-12

3. Updates in hematopoietic cell transplant and cellular therapies that enhance the risk for opportunistic infections;Transplant Infectious Disease;2023-07-18

4. Who is the patient at risk for EBV reactivation and disease: expert opinion focused on post-transplant lymphoproliferative disorders following hematopoietic stem cell transplantation;Expert Opinion on Biological Therapy;2023-03-28

5. Human leukocyte antigen 7/8-matched unrelated bone marrow transplantation using anti-thymocyte globulin in children;International Journal of Hematology;2023-03-07